{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:04:08Z","timestamp":1791374648316,"version":"4.3.1"},"reference-count":129,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.rbmo.2016.04.007","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T10:51:03Z","timestamp":1461927063000},"page":"15-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":128,"title":["The role of AMH in the pathophysiology of polycystic ovarian syndrome"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9243-8541","authenticated-orcid":false,"given":"Deepika","family":"Garg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2500-9904","authenticated-orcid":false,"given":"Reshef","family":"Tal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2016.04.007_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.1740001","article-title":"Developmental origin of polycystic ovary syndrome\u2013a hypothesis","volume":"174","author":"Abbott","year":"2002","journal-title":"J. Endocrinol"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0015","first-page":"715","article-title":"Anti-mullerian hormone as a predictive factor in assisted reproductive technique of polycystic ovary syndrome patients","volume":"49","author":"Aleyasin","year":"2011","journal-title":"Acta Med. Iran"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0020","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1093\/humrep\/dep271","article-title":"The value of measuring anti-M\u00fcllerian hormone in women with anovulatory polycystic ovary syndrome undergoing laparoscopic ovarian diathermy","volume":"24","author":"Amer","year":"2009","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0025","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/humrep\/deq019","article-title":"Concentrations of AMH and inhibin-B in relation to follicular diameter in normal human small antral follicles","volume":"25","author":"Andersen","year":"2010","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0030","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","article-title":"Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome","volume":"90","author":"Apridonidze","year":"2005","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0035","doi-asserted-by":"crossref","first-page":"4951","DOI":"10.1210\/endo.136.11.7588229","article-title":"Anti-mullerian hormone and anti-mullerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth","volume":"136","author":"Baarends","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0040","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1210\/jc.2005-1804","article-title":"Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin?","volume":"91","author":"Baillargeon","year":"2006","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0045","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.fertnstert.2006.08.096","article-title":"Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology","volume":"87","author":"Bayrak","year":"2007","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0050","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0092-8674(94)90251-8","article-title":"Mullerian-inhibiting substance function during mammalian sexual development","volume":"79","author":"Behringer","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0055","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00404-013-2833-9","article-title":"Anti-Mullerian hormone and insulin resistance in classic phenotype lean PCOS","volume":"288","author":"Caglar","year":"2013","journal-title":"Arch. Gynecol. Obstet"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0060","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1093\/humrep\/dep074","article-title":"Anti-Mullerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome","volume":"24","author":"Carlsen","year":"2009","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0070","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/cen.12557","article-title":"Polycystic ovary syndrome and anti-Mullerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins","volume":"81","author":"Cassar","year":"2014","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0075","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0092-8674(86)90783-X","article-title":"Isolation of the bovine and human genes for Mullerian inhibiting substance and expression of the human gene in animal cells","volume":"45","author":"Cate","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0080","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1210\/jc.2008-1231","article-title":"Anti-Mullerian hormone, its receptor, FSH receptor, and androgen receptor genes are overexpressed by granulosa cells from stimulated follicles in women with polycystic ovary syndrome","volume":"93","author":"Catteau-Jonard","year":"2008","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0085","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.fertnstert.2013.04.019","article-title":"Antimullerian hormone inhibits follicle-stimulating hormone-induced adenylyl cyclase activation, aromatase expression, and estradiol production in human granulosa-lutein cells","volume":"100","author":"Chang","year":"2013","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0090","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/humrep\/den015","article-title":"The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome","volume":"23","author":"Chen","year":"2008","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0095","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3109\/09513590.2015.1056143","article-title":"1-h Postprandial glucose level is related to the serum anti-Mullerian hormone level in women with polycystic ovary syndrome","volume":"31","author":"Chun","year":"2015","journal-title":"Gynecol. Endocrinol"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0100","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000132332","article-title":"Mapping of the gene for anti-mullerian hormone to the short arm of human chromosome 19","volume":"44","author":"Cohen-Haguenauer","year":"1987","journal-title":"Cytogenet. Cell Genet"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0105","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2265.1993.tb02419.x","article-title":"Clinical implications of hyperinsulinaemia in women","volume":"39","author":"Conway","year":"1993","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0110","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0015-0282(99)00639-1","article-title":"Serum mullerian-inhibiting substance levels during normal menstrual cycles","volume":"73","author":"Cook","year":"2000","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0115","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1242\/dev.114.3.721","article-title":"A quantitative and interspecific test for biological activity of anti-mullerian hormone: the fetal ovary aromatase assay","volume":"114","author":"di Clemente","year":"1992","journal-title":"Development"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0120","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1093\/humrep\/den185","article-title":"Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome","volume":"23","author":"Das","year":"2008","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0125","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.fertnstert.2009.03.004","article-title":"Increased anti-Mullerian hormone and decreased FSH levels in follicular fluid obtained in women with polycystic ovaries at the time of follicle puncture for in vitro fertilization","volume":"94","author":"Desforges-Bullet","year":"2010","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0130","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/humrep\/dem060","article-title":"The excess in 2\u20135\u2009mm follicles seen at ovarian ultrasonography is tightly associated to the follicular arrest of the polycystic ovary syndrome","volume":"22","author":"Dewailly","year":"2007","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0135","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","article-title":"A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile","volume":"84","author":"Diamanti-Kandarakis","year":"1999","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0140","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2265.2004.02170.x","article-title":"Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome","volume":"62","author":"Diamanti-Kandarakis","year":"2005","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0145","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00418-006-0265-3","article-title":"Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries","volume":"127","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Histochem. Cell Biol"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0150","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2265.2008.03247.x","article-title":"Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS)","volume":"69","author":"Diamanti-Kandarakis","year":"2008","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0155","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1530\/EJE-08-0510","article-title":"Anti-mullerian hormone is associated with advanced glycosylated end products in lean women with polycystic ovary syndrome","volume":"160","author":"Diamanti-Kandarakis","year":"2009","journal-title":"Eur. J. Endocrinol"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0160","doi-asserted-by":"crossref","DOI":"10.1177\/1535370215584937","article-title":"Advanced glycation end-products and insulin signaling in granulosa cells","author":"Diamanti-Kandarakis","year":"2015","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0165","first-page":"553","article-title":"Inhibitory effect of amh upon the expression of aromatase and lh receptors by cultured granulosa-cells of rat and porcine immature ovaries","volume":"2","author":"Diclemente","year":"1994","journal-title":"Endocrine"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0170","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0175","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2337\/diab.41.10.1257","article-title":"Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome","volume":"41","author":"Dunaif","year":"1992","journal-title":"Diabetes"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0180","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.1210\/endo.140.12.7204","article-title":"Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary","volume":"140","author":"Durlinger","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0185","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1210\/endo.142.11.8486","article-title":"Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary","volume":"142","author":"Durlinger","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0190","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S1472-6483(10)60379-3","article-title":"Clinical significance of serum concentration of anti-Mullerian hormone in obese women with polycystic ovary syndrome","volume":"15","author":"El-Halawaty","year":"2007","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0195","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1093\/humrep\/deh873","article-title":"Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism","volume":"20","author":"Eldar-Geva","year":"2005","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0200","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.fertnstert.2011.03.093","article-title":"Impact of laparoscopic ovarian drilling on anti-Mullerian hormone levels and ovarian stromal blood flow using three-dimensional power Doppler in women with anovulatory polycystic ovary syndrome","volume":"95","author":"Elmashad","year":"2011","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0205","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1210\/jcem-49-4-514","article-title":"Functional studies of aromatase activity in human granulosa cells from normal and polycystic ovaries","volume":"49","author":"Erickson","year":"1979","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0210","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1210\/er.2004-0004","article-title":"The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome","volume":"26","author":"Escobar-Morreale","year":"2005","journal-title":"Endocr. Rev"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0215","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0015-0282(97)81417-3","article-title":"Mullerian-inhibiting substance in follicular fluid and serum: a comparison of patients with tubal factor infertility, polycystic ovary syndrome, and endometriosis","volume":"67","author":"Fallat","year":"1997","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0220","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.fertnstert.2004.05.098","article-title":"Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment","volume":"83","author":"Fleming","year":"2005","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0225","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.rbmo.2015.06.015","article-title":"Assessing ovarian response: antral follicle count versus anti-Mullerian hormone","volume":"31","author":"Fleming","year":"2015","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0230","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1055\/s-0031-1272476","article-title":"Laparoscopic ovarian drilling for clomiphene-resistant polycystic ovary syndrome","volume":"29","author":"Flyckt","year":"2011","journal-title":"Semin. Reprod. Med"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0235","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3109\/09513590.2014.920004","article-title":"Anti-Mullerian hormone and insulin resistance in polycystic ovary syndrome","volume":"30","author":"Fonseca","year":"2014","journal-title":"Gynecol. Endocrinol"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0240","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"Franks","year":"1995","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0245","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0303-7207(99)00239-7","article-title":"Follicular dynamics in the polycystic ovary syndrome","volume":"163","author":"Franks","year":"2000","journal-title":"Mol. Cell. Endocrinol"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0250","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1365-2605.2005.00623.x","article-title":"Development of polycystic ovary syndrome: involvement of genetic and environmental factors","volume":"29","author":"Franks","year":"2006","journal-title":"Int. J. Androl"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0255","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.fertnstert.2007.03.066","article-title":"Mullerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture","volume":"89","author":"Grossman","year":"2008","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0260","series-title":"Anti-M\u00fcllerian hormone (AMH) production by and AMH type II receptor (AMHRII) in normal human ovaries","author":"Hanna","year":"2006"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0265","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1093\/humrep\/deu237","article-title":"Short-term changes in hormonal profiles after laparoscopic ovarian laser evaporation compared with diagnostic laparoscopy for PCOS","volume":"29","author":"Hendriks","year":"2014","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0270","first-page":"854","article-title":"Mullerian inhibiting substance messenger ribonucleic acid expression in granulosa and Sertoli cells coincides with their mitotic activity","volume":"131","author":"Hirobe","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0275","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/humrep\/det015","article-title":"The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study","volume":"28","author":"Homburg","year":"2013","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0280","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00006254-198202000-00001","article-title":"Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called \u201chyperthecosis\u201d","volume":"37","author":"Hughesdon","year":"1982","journal-title":"Obstet. Gynecol. Surv"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0285","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1210\/jc.2013-1393","article-title":"Can anti-Mullerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data","volume":"98","author":"Iliodromiti","year":"2013","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0290","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/humupd\/dmu003","article-title":"The predictive accuracy of anti-Mullerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature","volume":"20","author":"Iliodromiti","year":"2014","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0295","first-page":"53","article-title":"Autocrine and paracrine Mullerian inhibiting substance hormone signaling in reproduction","volume":"55","author":"Ingraham","year":"2000","journal-title":"Recent Prog. Horm. Res"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0300","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.fertnstert.2014.04.046","article-title":"Role of vitamin D in ovarian physiology and its implication in reproduction: a systematic review","volume":"102","author":"Irani","year":"2014","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0305","doi-asserted-by":"crossref","first-page":"E886","DOI":"10.1210\/jc.2013-4374","article-title":"Vitamin D increases serum levels of the soluble receptor for advanced glycation end products in women with PCOS","volume":"99","author":"Irani","year":"2014","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0310","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1210\/jc.2015-2580","article-title":"Vitamin D supplementation decreases TGF-beta1 bioavailability in PCOS: a randomized placebo-controlled trial","volume":"100","author":"Irani","year":"2015","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0315","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/molehr\/gat024","article-title":"Which follicles make the most anti-Mullerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection","volume":"19","author":"Jeppesen","year":"2013","journal-title":"Mol. Hum. Reprod"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0320","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/humupd\/dmh010","article-title":"The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest","volume":"10","author":"Jonard","year":"2004","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0325","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0303-7207(01)00467-1","article-title":"Anti-Mullerian hormone and its receptors","volume":"179","author":"Josso","year":"2001","journal-title":"Mol. Cell. Endocrinol"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0330","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/CS20080494","article-title":"RAGE: a novel biological and genetic marker for vascular disease","volume":"116","author":"Kalea","year":"2009","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0335","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1016\/j.fertnstert.2009.12.002","article-title":"Serum antimullerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle are predictive of the fertilization, implantation, and pregnancy in polycystic ovary syndrome patients undergoing assisted reproduction","volume":"94","author":"Kaya","year":"2010","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0340","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.4161\/mabs.29316","article-title":"The human Mullerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer. Validation using the mAb 12G4","volume":"6","author":"Kersual","year":"2014","journal-title":"MAbs"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0345","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1210\/jc.2007-2205","article-title":"A functional anti-mullerian hormone gene polymorphism is associated with follicle number and androgen levels in polycystic ovary syndrome patients","volume":"93","author":"Kevenaar","year":"2008","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0350","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/humrep\/den353","article-title":"Variants in the ACVR1 gene are associated with AMH levels in women with polycystic ovary syndrome","volume":"24","author":"Kevenaar","year":"2009","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0355","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1530\/rep.1.01074","article-title":"TGF-beta superfamily members and ovarian follicle development","volume":"132","author":"Knight","year":"2006","journal-title":"Reproduction"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0360","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0365","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jsbmb.2006.12.051","article-title":"Novel pathways that contribute to the anti-proliferative and chemopreventive activities of calcitriol in prostate cancer","volume":"103","author":"Krishnan","year":"2007","journal-title":"J. Steroid Biochem. Mol. Biol"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0370","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1365-2265.2006.02533.x","article-title":"Anti-Mullerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool?","volume":"64","author":"La Marca","year":"2006","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0375","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1093\/humrep\/deh508","article-title":"Anti-Mullerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation","volume":"19","author":"La Marca","year":"2004","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0380","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.fertnstert.2004.06.001","article-title":"Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics","volume":"82","author":"La Marca","year":"2004","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0385","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/humrep\/del421","article-title":"Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology","volume":"22","author":"La Marca","year":"2007","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0390","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/00006254-200211000-00022","article-title":"New approach to polycystic ovary syndrome and other forms of anovulatory infertility","volume":"57","author":"Laven","year":"2002","journal-title":"Obstet. Gynecol. Surv"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0395","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1210\/jc.2003-030932","article-title":"Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age","volume":"89","author":"Laven","year":"2004","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0400","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1095\/biolreprod35.5.1217","article-title":"Monoclonal antibodies raised against bovine anti-mullerian hormone: bovine, ovine, and caprine hormones share a set of identical epitopes","volume":"35","author":"Legeai","year":"1986","journal-title":"Biol. Reprod"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0405","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1600-0897.1988.tb00232.x","article-title":"A monoclonal antibody against human testicular anti-mullerian hormone","volume":"18","author":"Legeai","year":"1988","journal-title":"Am. J. Reprod. Immunol. Microbiol"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0410","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.fertnstert.2011.04.003","article-title":"Antimullerian hormone and polycystic ovary syndrome","volume":"96","author":"Lin","year":"2011","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0415","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1210\/jc.2013-2193","article-title":"The predictive value of circulating anti-Mullerian hormone in women with polycystic ovarian syndrome receiving clomiphene citrate: a prospective observational study","volume":"98","author":"Mahran","year":"2013","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0420","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1210\/en.2008-1555","article-title":"Interaction of the vitamin D receptor with a vitamin D response element in the Mullerian-inhibiting substance (MIS) promoter: regulation of MIS expression by calcitriol in prostate cancer cells","volume":"150","author":"Malloy","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0425","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1101\/gad.14.6.627","article-title":"Controlling TGF-beta signaling","volume":"14","author":"Massague","year":"2000","journal-title":"Genes Dev"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0430","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/j.fertnstert.2015.07.325","article-title":"Vitamin D attenuates the adverse effect of advanced glycation end products on human granulosa cells: implications for women with PCOS","volume":"104","author":"Merhi","year":"2015","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0435","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1530\/rep.1.01178","article-title":"Developmental expression and cellular distribution of Mullerian inhibiting substance in the primate ovary","volume":"132","author":"Modi","year":"2006","journal-title":"Reproduction"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0440","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1210\/jc.2007-1188","article-title":"The use of anti-mullerian hormone in predicting menstrual response after weight loss in overweight women with polycystic ovary syndrome","volume":"92","author":"Moran","year":"2007","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0445","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1093\/humrep\/deh373","article-title":"Changes in anti-Mullerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility","volume":"19","author":"Mulders","year":"2004","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0450","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/j.1471-0528.2005.00670.x","article-title":"Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?","volume":"112","author":"Muttukrishna","year":"2005","journal-title":"BJOG"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0455","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1093\/humrep\/dep225","article-title":"The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome","volume":"24","author":"Nardo","year":"2009","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0460","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3109\/09513590.2012.696753","article-title":"Therapeutic implications of vitamin D and calcium in overweight women with polycystic ovary syndrome","volume":"28","author":"Pal","year":"2012","journal-title":"Gynecol. Endocrinol"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0465","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1210\/jc.2009-2106","article-title":"Serum anti-mullerian hormone concentrations are elevated in oligomenorrheic girls without evidence of hyperandrogenism","volume":"95","author":"Park","year":"2010","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0470","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2265.2009.03614.x","article-title":"Association of insulin resistance with anti-Mullerian hormone levels in women without polycystic ovary syndrome (PCOS)","volume":"72","author":"Park","year":"2010","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0475","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1210\/jc.2006-1582","article-title":"Granulosa cell production of anti-Mullerian hormone is increased in polycystic ovaries","volume":"92","author":"Pellatt","year":"2007","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0480","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1530\/REP-09-0415","article-title":"Anti-Mullerian hormone and polycystic ovary syndrome: a mountain too high?","volume":"139","author":"Pellatt","year":"2010","journal-title":"Reproduction"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0485","series-title":"Anti-M\u00fcllerian hormone (AMH) inhibits aromatase expression in granulosa cells from human ovaries","author":"Pellatt","year":"2007"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0490","doi-asserted-by":"crossref","first-page":"18961","DOI":"10.1016\/S0021-9258(18)37375-7","article-title":"Proteolytic processing of mullerian inhibiting substance produces a transforming growth factor-beta-like fragment","volume":"263","author":"Pepinsky","year":"1988","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0495","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/humrep\/des460","article-title":"Loss of LH-induced down-regulation of anti-Mullerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome","volume":"28","author":"Pierre","year":"2013","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0500","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1210\/jc.2003-030727","article-title":"Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest","volume":"88","author":"Pigny","year":"2003","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0505","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/humrep\/deh850","article-title":"Serum anti-Mullerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome","volume":"20","author":"Piltonen","year":"2005","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0510","doi-asserted-by":"crossref","first-page":"E238","DOI":"10.1152\/ajpendo.90684.2008","article-title":"Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels","volume":"296","author":"Piouka","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0515","first-page":"3836","article-title":"Expression of anti-Mullerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells","volume":"84","author":"Rajpert-De Meyts","year":"1999","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0520","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mce.2003.09.007","article-title":"AMH\/MIS: what we know already about the gene, the protein and its regulation","volume":"211","author":"Rey","year":"2003","journal-title":"Mol. Cell. Endocrinol"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0525","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0530","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3109\/09513590.2013.769519","article-title":"Anti-Mullerian hormone and polycystic ovary syndrome: assessment of the clinical pregnancy rates in in vitro fertilization patients","volume":"29","author":"Sahmay","year":"2013","journal-title":"Gynecol. Endocrinol"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0535","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1042\/bj20031961","article-title":"The anti-Mullerian hormone type II receptor: insights into the binding domains recognized by a monoclonal antibody and the natural ligand","volume":"379","author":"Salhi","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.rbmo.2016.04.007_bib0540","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/BF03345785","article-title":"The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome","volume":"33","author":"Selimoglu","year":"2010","journal-title":"J. Endocrinol. Invest"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0545","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.mefs.2014.02.004","article-title":"Evaluation of ultrasonographic and Anti-M\u00fcllerian Hormone (AMH) changes as predictors for ovarian reserve after laparoscopic ovarian drilling for women with polycystic ovarian syndrome","volume":"19","author":"Seyam","year":"2014","journal-title":"Middle East Fertil. Soc. J."},{"key":"10.1016\/j.rbmo.2016.04.007_bib0550","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/j.fertnstert.2008.03.034","article-title":"Correlation of antimullerian hormone and baseline follicle-stimulating hormone levels","volume":"91","author":"Singer","year":"2009","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0555","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ejogrb.2011.06.006","article-title":"Is the plasma anti-Mullerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?","volume":"158","author":"Skalba","year":"2011","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0560","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","article-title":"Amenorrhea associated with bilateral polycystic ovaries","volume":"29","author":"Stein","year":"1935","journal-title":"Am. J. Obstet. Gynecol"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0565","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.fertnstert.2007.10.067","article-title":"Clinical uses of anti-Mullerian hormone assays: pitfalls and promises","volume":"91","author":"Streuli","year":"2009","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0570","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.1210\/jc.2005-0907","article-title":"Anti-mullerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries","volume":"90","author":"Stubbs","year":"2005","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0575","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ajog.2014.02.026","article-title":"Characterization of women with elevated antimullerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes","volume":"211","author":"Tal","year":"2014","journal-title":"Am. J. Obstet. Gynecol"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0580","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.fertnstert.2014.09.041","article-title":"Antimullerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis","volume":"103","author":"Tal","year":"2015","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0585","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1093\/humrep\/dep101","article-title":"The effect of weight loss on anti-Mullerian hormone levels in overweight and obese women with polycystic ovary syndrome and reproductive impairment","volume":"24","author":"Thomson","year":"2009","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0590","doi-asserted-by":"crossref","first-page":"836","DOI":"10.3109\/09513590.2014.943719","article-title":"Serum anti-Mullerian hormone and insulin resistance in the main phenotypes of non-obese polycystic ovarian syndrome women in China","volume":"30","author":"Tian","year":"2014","journal-title":"Gynecol. Endocrinol"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0595","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1210\/endo-125-2-1060","article-title":"Mullerian inhibiting substance in the adult rat ovary during various stages of the estrous cycle","volume":"125","author":"Ueno","year":"1989","journal-title":"Endocrinology"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0600","doi-asserted-by":"crossref","first-page":"987","DOI":"10.2174\/138161208784139747","article-title":"Advanced glycation end products and insulin resistance","volume":"14","author":"Unoki","year":"2008","journal-title":"Curr. Pharm. Des"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0605","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/ncpendmet0400","article-title":"The genetics of the polycystic ovary syndrome","volume":"3","author":"Urbanek","year":"2007","journal-title":"Nat. Clin. Pract. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0610","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1172\/JCI2081","article-title":"Androgens stimulate early stages of follicular growth in the primate ovary","volume":"101","author":"Vendola","year":"1998","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0615","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1210\/endo-111-4-1409","article-title":"A sensitive radioimmunoassay for bovine anti-Mullerian hormone, allowing its detection in male and freemartin fetal serum","volume":"111","author":"Vigier","year":"1982","journal-title":"Endocrinology"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0620","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1210\/endo-114-4-1315","article-title":"Production of anti-Mullerian hormone: another homology between Sertoli and granulosa cells","volume":"114","author":"Vigier","year":"1984","journal-title":"Endocrinology"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0625","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1210\/jc.2005-1494","article-title":"Heritability of polycystic ovary syndrome in a Dutch twin-family study","volume":"91","author":"Vink","year":"2006","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0630","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/rep.1.00529","article-title":"Anti-Mullerian hormone: a new marker for ovarian function","volume":"131","author":"Visser","year":"2006","journal-title":"Reproduction"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0635","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/molehr\/gah015","article-title":"Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment","volume":"10","author":"Weenen","year":"2004","journal-title":"Mol. Hum. Reprod"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0640","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/09513590701485212","article-title":"and Jultanmas R. Ovarian reserve in women with polycystic ovary syndrome who underwent laparoscopic ovarian drilling","volume":"23","author":"Weerakiet","year":"2007","journal-title":"Gynecol. Endocrinol"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0645","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1210\/jcem.84.8.5929","article-title":"Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development","volume":"84","author":"Weil","year":"1999","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0650","first-page":"247","article-title":"Mullerian inhibiting substance requires its N-terminal domain for maintenance of biological activity, a novel finding within the transforming growth factor-beta superfamily","volume":"7","author":"Wilson","year":"1993","journal-title":"Mol. Endocrinol"},{"key":"10.1016\/j.rbmo.2016.04.007_bib0655","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10815-012-9726-x","article-title":"Correlation of serum Anti-Mullerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle with assisted reproduction outcome in polycystic ovary syndrome patients","volume":"29","author":"Xi","year":"2012","journal-title":"J. Assist. Reprod. Genet"}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648316300700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648316300700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T04:36:29Z","timestamp":1655613389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648316300700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":129,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S1472648316300700"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2016.04.007","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of AMH in the pathophysiology of polycystic ovarian syndrome","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2016.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}